Observations placeholder
Moxifloxacin
Identifier
001144
Type of Spiritual Experience
Background
A description of the experience
Moxifloxacin is a synthetic fluoroquinolone antibacterial agent, marketed worldwide (as the hydrochloride) under the brand names Avelox , Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, Moxeza for the treatment of conjunctivitis (pink eye).
On Jan, 09, 2017 666 people reported to have side effects when taking Moxifloxacin Hydrochloride. Among them, 5 people (0.75%) have Hallucination
On Dec, 28, 2016 2,283 people reported to have side effects when taking Moxifloxacin. Among them, 31 people (1.36%) have Hallucination
On Dec, 28, 2016 22,613 people reported to have side effects when taking Avelox. Among them, 271 people (1.2%) have Hallucination
On Jan, 19, 2017 1,418 people reported to have side effects when taking Vigamox. Among them, 10 people (0.71%) have Hallucination
The licensed uses for moxifloxacin are quite limited as moxifloxacin is to be considered a drug of last resort when all other antibiotics have failed. There are currently only six approved uses in the adult population (three of which are restricted) and Vigamox (ophthalmic) is the only one used for children.
Moxifloxacin is used to treat a number of infections including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis
Moxifloxacin interacts with a number of other drugs, as well as a number of herbal and natural supplements.
As of 2011 the FDA has added two boxed warnings for this drug in reference to spontaneous tendon ruptures and the fact that moxifloxacin may cause worsening of myasthenia gravis symptoms, including muscle weakness and breathing problems. Such an adverse reaction is a potentially life-threatening event and may require ventilatory support.
“Recent studies have demonstrated a correlation between mammalian cell cytotoxicity of the quinolones and the induction of micronuclei. As such, some fluoroquinolones, including moxifloxacin, may cause injury to the chromosome of eukaryotic cells.
There continues to be considerable debate as to whether or not this DNA damage is to be considered one of the mechanisms of action concerning the severe adverse reactions experienced by some patients following fluoroquinolone therapy”
Time on Avelox when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 98.89% | 1.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Avelox :
| Female | Male | |
| Hallucination | 69.06% | 30.94% |
Age of people who have Hallucination when taking Avelox :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.49% | 0.00% | 10.19% | 10.68% | 15.53% | 14.56% | 48.54% |
Severity of Hallucination when taking Avelox :
| least | moderate | severe | most severe | |
| Hallucination | 0.00% | 0.00% | 100.00% | 0.00% |
On Mar, 20, 2015: 20,150 people reported to have side effects when taking Avelox. Among them, 330 people (1.64%) have Death.
Time on Avelox when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 96.05% | 3.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |